Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP552020.RAk3dTzLX8cvSuZ47En9rfSdCBePXRm9grY92JWUKuBdA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP552020.RAk3dTzLX8cvSuZ47En9rfSdCBePXRm9grY92JWUKuBdA130_assertion type Assertion NP552020.RAk3dTzLX8cvSuZ47En9rfSdCBePXRm9grY92JWUKuBdA130_head.
- NP552020.RAk3dTzLX8cvSuZ47En9rfSdCBePXRm9grY92JWUKuBdA130_assertion wasGeneratedBy ECO_0000203 NP552020.RAk3dTzLX8cvSuZ47En9rfSdCBePXRm9grY92JWUKuBdA130_provenance.
- NP552020.RAk3dTzLX8cvSuZ47En9rfSdCBePXRm9grY92JWUKuBdA130_assertion wasDerivedFrom befree-2016 NP552020.RAk3dTzLX8cvSuZ47En9rfSdCBePXRm9grY92JWUKuBdA130_provenance.
- NP552020.RAk3dTzLX8cvSuZ47En9rfSdCBePXRm9grY92JWUKuBdA130_assertion SIO_000772 16733374 NP552020.RAk3dTzLX8cvSuZ47En9rfSdCBePXRm9grY92JWUKuBdA130_provenance.
- NP552020.RAk3dTzLX8cvSuZ47En9rfSdCBePXRm9grY92JWUKuBdA130_assertion evidence source_evidence_literature NP552020.RAk3dTzLX8cvSuZ47En9rfSdCBePXRm9grY92JWUKuBdA130_provenance.
- NP552020.RAk3dTzLX8cvSuZ47En9rfSdCBePXRm9grY92JWUKuBdA130_assertion description "[151 naive HCV-RNA positive patients presenting with biopsy- proven chronic hepatitis C and elevated ALT were randomised in a 2: 1 ratio in two arms: IFN-alpha 3 MU thrice a week (tiw) for 24 weeks (non-induced patients); IFN-alpha 6 MU daily for two weeks, then 3 MU daily for two weeks then 3 MU tiw for 20 weeks (induced patients).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP552020.RAk3dTzLX8cvSuZ47En9rfSdCBePXRm9grY92JWUKuBdA130_provenance.